The Class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions

被引:148
作者
Langer, JA [1 ]
Cutrone, EC
Kotenko, S
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA
[2] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA
关键词
cytokines; interferons; cytokine receptors;
D O I
10.1016/j.cytogfr.2003.10.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Expanded genomic information has driven the discovery of new members of the human Class 11 family of cytokine receptors (CRF2), which now includes 12 proteins. The corresponding cytokines have been identified, paired with their receptors and initially characterized for function. These cytokines include: a new human Type I IFN, IFN-kappa; molecules related to IL-10 (IL-19, IL-20, IL-22, IL-24, IL-26); and IFN-lambdas (IL-28/29), which have antiviral and cell stimulatory activities reminiscent of Type I IFNs, but act through a distinct receptor. In response to ligand binding, the CRF2 proteins form heterodimers, leading to cytokine-specific cellular responses; these diverse physiological functions are just beginning to be explored. Progress in structural and mutational analysis of ligand-receptor interactions now presents a more reliable framework for understanding receptor-ligand interactions, and for predicting key regions in less well studied members of the CRF2 family. The relationships between the CRF2 proteins will be summarized, as will the progress in identifying patterns of receptor interactions with ligands. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:33 / 48
页数:16
相关论文
共 103 条
  • [61] Chimeric erythropoietin-interferon gamma receptors reveal differences in functional architecture of intracellular domains for signal transduction
    Muthukumaran, G
    Kotenko, S
    Donnelly, R
    Ihle, JN
    Pestka, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (08) : 4993 - 4999
  • [62] Interleukins 19, 20, and 24 signal through two distinct receptor complexes - Differences in receptor-ligand interactions mediate unique biological functions
    Novak, JP
    Xu, WF
    Brender, T
    Yao, L
    Jones, C
    West, J
    Brandt, C
    Jelinek, L
    Madden, K
    McKernan, PA
    Foster, DC
    Jaspers, S
    Chandrasekher, YA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (49) : 47517 - 47523
  • [63] SOLUBLE AND MEMBRANE-ANCHORED FORMS OF THE HUMAN IFN-ALPHA/BETA RECEPTOR
    NOVICK, D
    COHEN, B
    TAL, N
    RUBINSTEIN, M
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1995, 57 (05) : 712 - 718
  • [64] THE HUMAN INTERFERON-ALPHA/BETA RECEPTOR - CHARACTERIZATION AND MOLECULAR-CLONING
    NOVICK, D
    COHEN, B
    RUBINSTEIN, M
    [J]. CELL, 1994, 77 (03) : 391 - 400
  • [65] SOLUBLE INTERFERON-ALPHA RECEPTOR MOLECULES ARE PRESENT IN BODY-FLUIDS
    NOVICK, D
    COHEN, B
    RUBINSTEIN, M
    [J]. FEBS LETTERS, 1992, 314 (03) : 445 - 448
  • [66] Cytokine signaling in 2002: New surprises in the Jak/Stat pathway
    O'Shea, JJ
    Gadina, M
    Schreiber, RD
    [J]. CELL, 2002, 109 : S121 - S131
  • [67] T lymphocytes constitutively produce an interferonlike cytokine limitin characterized as a heat- and acid-stable and heparin-binding glycoprotein
    Oritani, K
    Hirota, S
    Nakagawa, T
    Takahashi, I
    Kawamoto, S
    Yamada, M
    Ishida, N
    Kadoya, T
    Tomiyama, Y
    Kincade, PW
    Matsuzawa, Y
    [J]. BLOOD, 2003, 101 (01) : 178 - 185
  • [68] Limitin: An interferon-like cytokine that preferentially influences B-lymphocyte precursors
    Oritani, K
    Medina, KL
    Tomiyama, Y
    Ishikawa, J
    Okajima, Y
    Ogawa, M
    Yokota, T
    Aoyama, K
    Takahashi, I
    Kincade, PW
    Matsuzawa, Y
    [J]. NATURE MEDICINE, 2000, 6 (06) : 659 - 666
  • [69] Limitin: an interferon-like cytokine without myeloerythroid suppressive properties
    Oritani, K
    Kincade, PW
    Tomiyama, Y
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 2001, 79 (04): : 168 - 174
  • [70] Cloning and characterization of soluble and transmembrane isoforms of a novel component of the murine type I interferon receptor, IFNAR 2
    Owczarek, CM
    Hwang, SY
    Holland, KA
    Gulluyan, LM
    Tavaria, M
    Weaver, B
    Reich, NC
    Kola, I
    Hertzog, PJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (38) : 23865 - 23870